(Note: IPOScoop has NO Call on this micro-cap unit offering. Each unit consists of one share of common stock and one warrant to buy one share of common stock.) We are a clinical biopharmaceutical company whose first product candidate, RenovoGem, is a drug and device combination of intra-arterial gemcitabine and RenovoCath. The FDA has granted […]

(Note: IPOScoop has No Call on this micro-cap IPO. The company changed the IPO’s terms to a unit offering in an S-1/A filing on Aug. 6, 2021, a shift from its initial plans to offer only shares of common stock. Under the amended terms, the company’s stock will trade under the proposed symbol “DRMA” and […]

(Note: This is a unit offering. IPOScoop has NO CALL on this IPO because this is a micro-cap unit offering. The common stock will trade on the NASDAQ under the proposed symbol “DATS” and the warrants under the proposed symbol “DATSW”. Each unit consists of one share of our common stock and one Series A […]

We intend to focus on consumer-facing companies with a significant Africa presence or a compelling Africa potential, which complements the expertise of our management team. (Incorporated in Delaware) Marcus Choo Yeow Ngoh is our CEO. He has over 15 years of experience in the business and entrepreneurship world, building great consumer products and companies. His accomplished […]

AfterNext is a special purpose acquisition company that we created to acquire an innovative company that seeks access to the public financial markets and the intellectual capital of our team to help propel and accelerate the adoption of technologies across healthcare in the new HealthTech arena. (Incorporated in the Cayman Islands) 

We currently intend to concentrate our acquisition efforts on business merger targets within InsurTech (as defined below) and blockchain technology sectors where we believe our experience and access to public markets can be a catalyst for accelerating growth. While we may pursue a business combination outside of that sector or industry, including financial technologies, real estate, […]

We will seek a target in the disruptive technology sector with a spotlight on companies in Asia, with Japan in particular (but expressly not in China or Hong Kong). Japan is home to some of the most well-known companies, particularly in the area of consumer electronics. In recent years, more and more private equity firms are […]

We believe the financial services and the financial technology sectors in the U.S. and EMEA as well as relevant technology firms supporting these sectors present particularly attractive investment opportunities. (Incorporated in the Cayman Islands)  Xavier Rolet KBE (Knight of the British Empire) is the CEO, chairman and co-founder of World Quantum Growth Acquisition Corp. Named […]

We intend to focus on industries that complement our sponsor’s and management team’s backgrounds in technology, digitalization, and disruption. As described further below, we currently intend to consummate our initial business combination with an independent company in sectors that The Production Board, LLC (“TPB” or “The Production Board”), the parent company of our sponsor, TPB […]

We currently intend to focus our efforts on identifying high growth technology and tech-enabled businesses domestically and abroad in the consumer internet, ecommerce, software, healthcare, transportation / mobility and financial services industries, as well as other industries that are being disrupted by advances in technology and on technology paradigms including artificial intelligence (“AI”), automation, data […]